P1121 EARLY STOPPING RULES FOR FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: EXPLORATORY STUDY OF POOLED DATA FROM PHASE III TRIALS

✍ Scribed by Ferenci, P.; Dieterich, D.; Zeuzem, S.; Mantry, P.; Sarrazin, C.; Crespo, J.; Tam, E.; Dufour, J.-F.; Yoshida, E.M.; Nishiguchi, S.; Bourlière, M.; Omata, M.; Abergel, A.; Kuboki, M.; Carvalho, A.; Peng, C.-Y.; Romero-Gómez, M.; Wright, D.; Stern, J.O.; Böcher, W.; Kukolj, G.; Gallivan, J.-P.; Scherer, J.; Jensen, D.M.

• Book ID: 122305022
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 83 KB
• Volume: 60
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(14)61281-2